Bogart Chris

Bogart Chris appears in our data through filings on InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) shares, published by SEDI. In total, 29 filings cover trades dated from 2 February 2016 to 11 July 2017.

Market trades split into 25 purchases (€207k) and 3 sales (€168k). Purchases outweigh sales by €39k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2017 to date brings 1 purchase and no sales.

The median purchase comes to €1,112. The 25 purchases reviewed show no overlap with other insiders buying the same stock within a month.

On 11 July 2017 came the latest disclosure, an open-market purchase for €4,320 in InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,). The median gap between a trade and its publication by SEDI is 4 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.